SCHEMBL3676580

SCHEMBL3676580

CCOC(=O)c1ccc(N)c(F)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
HSD17B10 Q99714 1/20 0.53
TSHR P16473 1/20 0.47
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAOA P21397 1/20 0.44
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 2/20 0.42
TP53 P04637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27556629 0.85 ALDH1A1 (0.57) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL31535424 0.83 TSHR (0.49) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL23537740 0.82 ABL1 (0.56) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL7499227 0.81 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL24717780 0.81 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL30798553 0.81 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL3793069 0.80 ALDH1A1 (0.51) ALDH1A1HSD17B10TSHRLMNACYP1A2
SCHEMBL21596124 0.79 HDAC4 (0.46) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL3018457 0.78 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRCA12CA1
SCHEMBL21596127 0.78 TSHR (0.44) ALDH1A1HSD17B10TSHRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170830-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2010-04-07 EP disclosed
WO-2009012283-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2009-01-22 WO disclosed